Navigation Links
Jan Marini Skin Research Introduces Age Intervention(R) Transitions - a New Frontier in Skin Care
Date:2/27/2008

SAN JOSE, Calif., Feb. 27 /PRNewswire/ -- Jan Marini Skin Research, Inc. (JMSR; http://www.janmarini.com) today announced the launch of Age Intervention Transitions, an extraordinary new technology that addresses common female transitional issues such as stubborn adult acne as well as fine lines and wrinkles, coarse skin texture and discoloration.

Age Intervention Transitions' unique formula resolves or minimizes acne breakouts while dramatically improving the appearance of follicle size, fine lines, rough facial texture and that nasty leftover acne discoloration.

Transitions combines acne clearing and prevention with remarkable skin resurfacing and brightening technology. No more stubborn acne -- just clear, radiantly polished and younger looking skin.

"Many people experience transitional skin care issues as they age, including adult acne, fine lines, and the effects of cumulative sun exposure," says Jan Marini, president and CEO of Jan Marini Skin Research, Inc. "I created this revolutionary formula to address these two common conditions that plague a huge percentage of adult females."

Age Intervention Transitions benefits:

-- Resolves or minimizes stubborn resistant adult acne

-- Resurfaces skin texture for a more refined, polished and radiant look

-- Improves the appearance of fine lines and wrinkles

-- Significantly and rapidly lessens leftover acne discoloration for a

brighter, more even-toned appearance

Age Intervention Transitions is offered in a 1 oz. pump bottle.

About Jan Marini Skin Research, Inc.

San Jose, CA-based Jan Marini Skin Research, Inc. (JMSR) is a recognized leader and innovator in skin care, providing state of the art technologies and breakthroughs in medically-based skin care therapies. The JMSR Skin Care Management System is used and trusted by physicians and skin care professionals worldwide to ensure optimum results for their patients and clients. JMSR products range from Glycolic Acid formulas and patented breakthroughs to the state-of-the-art anti-aging properties of the remarkable C-ESTA(R) family of products, all aimed at addressing aging skin, acne, rosacea and other common skin concerns. For more information, please visit http://www.janmarini.com.


'/>"/>
SOURCE Jan Marini Skin Research, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jan Marini Skin Research Suspends Sales of Popular Eyelash Products
2. Jan Marini Skin Research Gives Familiar Logo a Facelift
3. Jan Marini Skin Research Adds Two New Sheer Colors to Antioxidant Daily Face Protectant SPF 30 With PhytoMelanin(TM)
4. Efforts to Recruit, Retain and Research Nations Social Workers Gain Bipartisan Support in Congress
5. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
6. AMA Foundation Announces Seed Grant Research Recipients
7. The Low-Fat Diet is Fueling Our Rate of Obesity, Says Researcher Phoenix Gilman
8. NIH awards OHSU researcher $1.2 million to determine causes of, risk factors for pelvic floor injury
9. Researchers identify and shut down protein that fuels ovarian cancer
10. Implementers, Advocates, Researchers Call on Congress to Honor Lantos Commitment to Public Health and Human Rights by Placing Evidence over Ideology
11. Penn researchers engineer first system of human nerve-cell tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... and infrastructure. Most providers, however, are unsure how to move forward, given the ... to define a path forward tailored to an organization’s specific needs. , PYA ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  The National Pharmaceutical ... joined the health policy research organization as its ... , MD, senior vice president and chief scientific ... representative on the NPC Board of Directors. ... that Mallinckrodt has joined us in support of ...
(Date:6/23/2016)... 23, 2016  Delcath Systems, Inc. (NASDAQ: ... focused on treatment of primary and metastatic liver cancers, ... education - www.againsttheodds.eu - has been awarded ... Awards. The website was developed ... and their families who are coping with the devastating ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. Stock-Callers.com has initiated coverage on the following equities: ... (NASDAQ: AMAG ), IDEXX Laboratories Inc. (NASDAQ: ... ADRO ). Learn more about these stocks by accessing their ...
Breaking Medicine Technology: